The DOI matches its Crossref record.
Substance‐P receptors in human primary neoplasms: Tumoral and vascular localization
Abstract
Primary human neoplasms were examined for the presence of substance‐P receptors by receptor autoradiography with 125 I‐labelled Bolton‐Hunter substance P. Substance‐P receptors were localized and characterized in the neoplastic cells of 9/12 astrocytomas, 10/10 glioblastomas, 10/12 medullary thyroid carcinomas, 8/16 breast carcinomas and 4/5 ganglioneuroblastomas. Conversely, substance‐P receptors were not or only rarely identified on non‐small‐cell carcinomas of the lung (1/16), neuroblastomas (0/8), adenocarcinomas of the colon (1/21) or the pancreas (1/9), or on malignant lymphomas (3/18). However, in the great majority of the investigated tumours, substance‐P receptors were found on intra‐ and peritumoral blood vessels. All substance‐P receptors detected had the pharmacological characteristics of the neurokinin‐I receptor sub‐type. In addition, the expression of somatostatin receptors was examined in all the neoplastic tissues mentioned above. Both substance‐P and somatostatin receptors were present in astrocytomas and in ganglioneuroblastomas, whereas little or no receptor was found in pancreatic and non‐small‐cell lung carcinomas. The extent of somatostatin‐receptor expression was inversely correlated to that of the substance‐P receptors in glioblastomas, neuroblastomas and non‐Hodgkin's lymphomas. The tumoral and vascular localization of substance‐P receptors in tumours may have clinical implications. The use of radiolabelled substance P for in vivo scintigraphy may supplement the current set of diagnostic tools. Substance‐P antagonists might be used in the treatment of tumours, as their binding to vascular receptors may decrease tumoral blood supply and drainage. © 1995 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Peptide Receptors as Molecular Targets for Cancer Diagnosis and Therapy
Reubi, J. C. (2003) · Endocrine Reviews · doi:10.1210/er.2002-0007 · Cited by 1,131
Self-citationAn Overview of Targeted Alpha Therapy with 225Actinium and 213Bismuth
Morgenstern, A., Apostolidis, C., Kratochwil, C., Sathekge, M., Krolicki, L., & Bruchertseifer, F. (2018) · Current Radiopharmaceuticals · doi:10.2174/1874471011666180502104524 · Cited by 370
The tachykinin NK1 receptor. Part II: Distribution and pathophysiological roles
Quartara, L., & Maggi, C. A. (1998) · Neuropeptides · doi:10.1016/s0143-4179(98)90015-4 · Cited by 292
The effects of tachykinins on inflammatory and immune cells
Maggi, C. A. (1997) · Regulatory Peptides · doi:10.1016/s0167-0115(97)00029-3 · Cited by 280
González-Santana, A., Marrero-Hernández, S., Dorta, I., Hernández, M., Pinto, F. M., Báez, D., Bello, A. R., Candenas, L., & Almeida, T. A. (2016) · Fertility and Sterility · doi:10.1016/j.fertnstert.2016.07.007 · Cited by 11
Metadata
- Authors
- Hennig, I. M., Laissue, J. A., Horisberger, U., & Reubi, J.
- Venue
- International Journal of Cancer
- Publisher
- Wiley
- Published
- 1995-06-09
- Volume
- 61
- Issue
- 6
- Pages
- 786-792
- ISSN
- 0020-7136 (ISSN-L)
- 1097-0215
- OpenAlex
- W1974412135
- Cited by
- 206
- References
- 0
- FWCI
- 2.41
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Substance‐P receptors in human primary neoplasms: Tumoral and vascular localization. https://app.cochat.ai/papers/10.1002/ijc.2910610608
- The paper
- Hennig, I. M., Laissue, J. A., Horisberger, U., & Reubi, J. (1995). Substance‐P receptors in human primary neoplasms: Tumoral and vascular localization. International Journal of Cancer. https://doi.org/10.1002/ijc.2910610608
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.